107 related articles for article (PubMed ID: 89173)
1. Cyclic GMP System in epidermis: I. Effect of ischemia.
Iizuka H; Adachi K; Halprin KM; Levine V
J Invest Dermatol; 1979 Sep; 73(3):220-3. PubMed ID: 89173
[TBL] [Abstract][Full Text] [Related]
2. Cyclic GMP system in the epidermis.
Adachi K; Aoyagi T; Iizuka H; Halprin KM; Levin V
Curr Probl Dermatol; 1980; 10():39-65. PubMed ID: 6263550
[TBL] [Abstract][Full Text] [Related]
3. Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form.
Lavan BE; Lakey T; Houslay MD
Biochem Pharmacol; 1989 Nov; 38(22):4123-36. PubMed ID: 2480793
[TBL] [Abstract][Full Text] [Related]
4. Nerve growth factor increases the cyclic GMP level and activates the cyclic GMP phosphodiesterase in PC12 cells.
Laasberg T; Pihlak A; Neuman T; Paves H; Saarma M
FEBS Lett; 1988 Nov; 239(2):367-70. PubMed ID: 2460374
[TBL] [Abstract][Full Text] [Related]
5. Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells.
Souness JE; Diocee BK; Martin W; Moodie SA
Biochem J; 1990 Feb; 266(1):127-32. PubMed ID: 2155604
[TBL] [Abstract][Full Text] [Related]
6. Role of selective cyclic GMP phosphodiesterase inhibition in the myorelaxant actions of M&B 22,948, MY-5445, vinpocetine and 1-methyl-3-isobutyl-8-(methylamino)xanthine.
Souness JE; Brazdil R; Diocee BK; Jordan R
Br J Pharmacol; 1989 Nov; 98(3):725-34. PubMed ID: 2480168
[TBL] [Abstract][Full Text] [Related]
7. Cyclic GMP metabolism in psoriasis: increased activity of soluble epidermal cyclic GMP phosphodiesterase and its modulation by calcium.
Cantieri JS; Graff G; Goldberg ND
Br J Dermatol; 1981 Mar; 104(3):301-5. PubMed ID: 6260127
[TBL] [Abstract][Full Text] [Related]
8. Photoaffinity labelling of cyclic GMP-inhibited phosphodiesterase (PDE III) in human and rat platelets and rat tissues: effects of phosphodiesterase inhibitors.
Tang KM; Jang EK; Haslam RJ
Eur J Pharmacol; 1994 Jun; 268(1):105-14. PubMed ID: 7925608
[TBL] [Abstract][Full Text] [Related]
9. Evidence that additional mechanisms to cyclic GMP mediate the decrease in intracellular calcium and relaxation of rabbit aortic smooth muscle to nitric oxide.
Weisbrod RM; Griswold MC; Yaghoubi M; Komalavilas P; Lincoln TM; Cohen RA
Br J Pharmacol; 1998 Dec; 125(8):1695-707. PubMed ID: 9886761
[TBL] [Abstract][Full Text] [Related]
10. Cyclic GMP system in epidermis: II. Histamine stimulates cyclic GMP formation.
Iizuka H; Adachi K; Aoyagi T; Halprin KM; Levine V
J Invest Dermatol; 1979 Nov; 73(5):313-6. PubMed ID: 227965
[No Abstract] [Full Text] [Related]
11. Activation of human lymphocyte high affinity cyclic AMP phosphodiesterase by culture with 1-methyl-3-isobutylxanthine.
Thompson WJ; Ross CP; Hersh EM; Epstein PM; Strada SJ
J Cyclic Nucleotide Res; 1980; 6(1):25-36. PubMed ID: 6155390
[TBL] [Abstract][Full Text] [Related]
12. The role of cGMP hydrolysing phosphodiesterases 1 and 5 in cerebral artery dilatation.
Kruuse C; Rybalkin SD; Khurana TS; Jansen-Olesen I; Olesen J; Edvinsson L
Eur J Pharmacol; 2001 May; 420(1):55-65. PubMed ID: 11412839
[TBL] [Abstract][Full Text] [Related]
13. A photoaffinity probe covalently modifies the catalytic site of the cGMP-binding cGMP-specific phosphodiesterase (PDE-5).
Corbin JD; Beasley A; Turko IV; Haik TL; Mangum KA; Wells JN; Francis SH; Sekhar KR
Cell Biochem Biophys; 1998; 29(1-2):145-57. PubMed ID: 9631243
[TBL] [Abstract][Full Text] [Related]
14. Effects of IBMX on the ERG of the isolated perfused cat eye.
Sandberg MA; Pawlyk BS; Crane WG; Schmidt SY; Berson EL
Vision Res; 1987; 27(9):1421-30. PubMed ID: 2451348
[TBL] [Abstract][Full Text] [Related]
15. Functional identification of phosphodiesterase activity in human trabecular meshwork cells.
Zhou L; Thompson WJ; Potter DE
J Ocul Pharmacol Ther; 2000 Aug; 16(4):317-22. PubMed ID: 10977127
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase inhibitor 3-isobutyl-methyl-xanthine affects rabbit ovaries and oviduct.
Sirotkin AV; Chrenek P; Chadio S; Xylouri E; Fotopouloy H; Makarevich AV
Eur J Pharmacol; 2010 Sep; 643(1):145-51. PubMed ID: 20599929
[TBL] [Abstract][Full Text] [Related]
17. Effects of phosphodiesterase inhibitors, imidazole and phosphate on cyclic CMP phosphodiesterase are different from those on cyclic AMP and cyclic GMP phosphodiesterases.
Kuo JF; Shoji M; Brackett NL; Helfman DM
J Cyclic Nucleotide Res; 1978 Dec; 4(6):463-74. PubMed ID: 85641
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of human lung cyclic GMP and cyclic AMP phosphodiesterases by certain nucleosides, nucleotides, and pharmacological phosphodiesterase inhibitors.
Glass WF; Moore JB
Biochem Pharmacol; 1979 Apr; 28(7):1107-12. PubMed ID: 87197
[No Abstract] [Full Text] [Related]
19. Cyclic nucleotide phosphodiesterases from frog atrial fibers: isolation and drug sensitivities.
Lugnier C; Gauthier C; Le Bec A; Soustre H
Am J Physiol; 1992 Mar; 262(3 Pt 2):H654-60. PubMed ID: 1373036
[TBL] [Abstract][Full Text] [Related]
20. A stimulating effect of guanyl nucleotides on the rat-liver soluble cyclic GMP high-affinity phosphodiesterase activity.
Spina A; Chiosi E; Paolisso G; Laurenza A; Illiano G
FEBS Lett; 1983 Jul; 157(2):351-5. PubMed ID: 6190680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]